Microvast Holdings, Inc. filings document the public reporting of an operating battery-technology company with Nasdaq-listed common stock and redeemable warrants. Recent Form 8-K reports cover operating results, financial presentations, material definitive agreements, executive officer changes, and stockholder-vote results for MVST.
Proxy materials describe annual-meeting matters such as director elections, auditor ratification, board structure, and shareholder voting mechanics. Capital-structure disclosures include common stock, warrants, and an at-the-market equity sales agreement, while earnings-related filings furnish consolidated results for Microvast's battery systems business.
Microvast Holdings, Inc. Chief Financial Officer Rodney Worthen has filed an initial ownership report showing beneficial ownership of 19,379 shares of common stock in the form of restricted stock units. These RSUs were granted under the company’s 2021 Equity Incentive Plan and each unit represents the right to receive one share of common stock.
The RSUs vest in three equal installments on November 8, 2025, 2026 and 2027, providing time-based equity compensation that aligns the CFO’s interests with the company’s longer-term performance.
Microvast Holdings, Inc. director Pan Yixin reported selling common stock in two transactions on December 31, 2025. The Form 4 shows open-market sales of 11,935 shares at a price of $2.76 per share and 661 shares at $2.78 per share. After these sales, Pan beneficially owns 130,739 shares of Microvast common stock, held as direct ownership.
Microvast Holdings, Inc. reported that its Chief Accounting Officer, Eric Garcia, received an equity award in the form of restricted stock units. On January 9, 2026, he was granted 28,571 RSUs, each representing a contingent right to receive one share of Microvast common stock at no purchase price. The award was made under the company’s 2021 Equity Incentive Plan and is reported as directly owned by Garcia.
The RSUs do not settle immediately; instead, they vest in near equal installments on January 9, 2027, 2028 and 2029. After the grant, Garcia is shown as beneficially owning 28,571 shares of common stock tied to this award, aligning with the RSU grant size.
Microvast Holdings, Inc. executive Eric Garcia, the company’s Chief Accounting Officer, filed an initial Form 3 reporting his ownership status. The filing states that no securities of Microvast are beneficially owned by him, and both the non-derivative and derivative securities tables show no holdings. The form is filed by a single reporting person and includes no insider transactions.
Microvast Holdings, Inc. reported leadership changes in its finance organization. The company hired Eric N. Garcia as Chief Accounting Officer, with an annual base salary of $350,000, a target bonus equal to 50% of salary, and a one-time restricted stock unit grant valued at $100,000 that vests in equal installments over three years, subject to continued employment.
Microvast also appointed Rodney Worthen, previously Interim Chief Financial Officer and Vice President of Corporate Strategy, as its permanent Chief Financial Officer. His annual base salary increases to $400,000, with a target bonus of 50% of salary, a one-time cash bonus of $30,000, and an initial restricted stock unit grant valued at $300,000, vesting in equal installments over three years, subject to continued employment. The company states there are no related-party or Item 404(a) relationships for either executive.
Microvast Holdings, Inc. furnished materials summarizing its unaudited condensed consolidated financial results for the period ended September 30, 2025. On November 10, 2025, the company announced a press release and an accompanying slideshow presentation outlining its Q3 2025 results.
The press release is provided as Exhibit 99.1 and the presentation as Exhibit 99.2. The information is furnished, not filed, and is therefore not subject to Section 18 liabilities of the Exchange Act, nor incorporated by reference into other filings except as specifically referenced.
Microvast Holdings (MVST) filed its Q3 2025 report, showing higher sales but continued bottom-line pressure and liquidity risks. Revenue rose to $123.3 million (from $101.4 million), lifting gross profit to $46.4 million. Operating income was $13.0 million, but a non-cash fair value loss on its convertible loan drove a net loss of $1.5 million.
For the nine months, revenue reached $331.1 million (from $266.4 million) with net cash from operating activities of $59.5 million. Cash and cash equivalents were $90.7 million plus $51.9 million in restricted cash as of September 30, 2025. Total liabilities were $655.5 million and equity $358.1 million.
The company disclosed conditions that raise substantial doubt about its ability to continue as a going concern, citing short-term debt and commitments. Management points to positive operating cash flow, refinancing activity, and an at‑the‑market equity program; after quarter‑end, it received $12.6 million in net proceeds under a Sales Agreement. Bank borrowings totaled $118.8 million (with $84.4 million current), and the fair value of the convertible loan was $193.5 million.
Microvast Holdings, Inc. reported the results of its 2025 Annual Meeting of stockholders held on October 23, 2025. A total of 192,887,067 shares were present, representing approximately 59.28% of the 325,354,111 shares outstanding as of August 26, 2025.
Stockholders elected director nominee Wei Ying with 123,485,834 votes for, 13,349,205 withheld, and 55,865,084 broker non‑votes. Stockholders also approved a separate proposal with 191,591,011 for, 1,176,675 against, and 119,381 abstentions.
Microvast Holdings, Inc. (MVST) discloses multiple outstanding and potentially dilutive securities and a broad set of material risk factors. The prospectus lists 29,020,343 shares issuable on outstanding stock options at a weighted-average exercise price of $5.72, 4,014,008 restricted stock units, 28,437,000 shares issuable on warrants at an exercise price of $11.50, 5,500,000 shares issuable on a CEO warrant at $2.00, and 50,000,000 shares issuable upon conversion of a convertible loan related to a Loan Agreement.
The filing highlights significant business risks, including concerns about the company’s ability to remain a going concern, the need for additional capital, manufacturing scale-up and quality risks, exposure to operations in China, mechanics liens, litigation, macroeconomic and supply-chain pressures, customer concentration and demand uncertainty, cybersecurity and regulatory compliance costs, and potential adverse effects of tariffs on China imports. The prospectus incorporates prior SEC filings for additional detail.
Microvast Holdings, Inc. entered into a Controlled Equity OfferingSM Sales Agreement that allows it to sell from time to time up to $125,000,000 of its common stock through Cantor Fitzgerald & Co. and Needham & Company, LLC as sales agents or principal. These sales will be made as at-the-market offerings under an effective shelf registration statement on Form S-3.
The company will pay the agents a commission of up to 3.0% of the aggregate gross proceeds from any sales. Microvast plans to use the net proceeds for general corporate purposes, which may include repaying or refinancing indebtedness, funding acquisitions, capital expenditures and working capital.